The emerging results suggest that MIF may play both a protective or pathogenetic role in neurodegenerative disorders, in particular with a dichotomic role in AD and Parkinson disease (PD), a potential protective action in amyotrophic lateral sclerosis (ALS), and a possible pathogenetic role in Huntington disease (HD). This evidence concerns the gene MIF and juvenile Huntington disease.